In patients with longstanding type 1 diabetes, blunting of the glucagon response comes along with the disappearing endogenous insulin production (Cryer, 2008), rendering the patients increasingly dependent upon epinephrine as protection against hypoglycemia. The gene discussed is GCG; the disease is type 1 diabetes mellitus.